BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $83,771,063 | -33.6% | 2,219,689 | -19.8% | 1.89% | -29.6% |
| Q2 2023 | $126,068,210 | +678.8% | 2,767,081 | +820.6% | 2.69% | +636.2% |
| Q3 2022 | $16,188,000 | +4990.6% | 300,562 | +7501.5% | 0.36% | +12066.7% |
| Q3 2021 | $318,000 | +439.0% | 3,954 | +440.9% | 0.00% | +200.0% |
| Q2 2021 | $59,000 | -91.4% | 731 | -91.4% | 0.00% | -92.3% |
| Q3 2020 | $684,000 | -24.4% | 8,511 | -19.0% | 0.01% | -31.6% |
| Q2 2020 | $905,000 | -77.9% | 10,510 | -79.2% | 0.02% | -77.9% |
| Q1 2020 | $4,094,000 | +100.9% | 50,424 | +106.9% | 0.09% | +186.7% |
| Q4 2019 | $2,038,000 | -42.5% | 24,373 | -39.9% | 0.03% | -42.3% |
| Q3 2019 | $3,545,000 | -51.2% | 40,524 | -54.3% | 0.05% | -50.5% |
| Q2 2019 | $7,262,000 | +37.7% | 88,670 | +36.7% | 0.10% | +50.0% |
| Q1 2019 | $5,275,000 | -75.5% | 64,870 | -80.2% | 0.07% | -77.8% |
| Q4 2018 | $21,527,000 | -66.5% | 327,060 | -60.7% | 0.32% | -60.4% |
| Q3 2018 | $64,174,000 | +817.4% | 832,450 | +669.3% | 0.80% | +806.8% |
| Q4 2017 | $6,995,000 | +97.2% | 108,210 | +91.4% | 0.09% | +95.6% |
| Q3 2017 | $3,548,000 | +47.5% | 56,540 | +42.3% | 0.04% | +50.0% |
| Q2 2017 | $2,405,000 | -16.9% | 39,730 | -28.8% | 0.03% | -18.9% |
| Q1 2017 | $2,893,000 | -8.6% | 55,790 | -21.9% | 0.04% | -9.8% |
| Q4 2016 | $3,166,000 | -1.2% | 71,400 | +6.0% | 0.04% | +7.9% |
| Q3 2016 | $3,206,000 | -3.8% | 67,360 | -8.6% | 0.04% | -15.6% |
| Q2 2016 | $3,333,000 | +189.8% | 73,700 | +144.5% | 0.04% | +164.7% |
| Q4 2015 | $1,150,000 | – | 30,140 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |